Inhibition of TSH Activation of Human Cultured Thyroid Cells by Tumor Necrosis Factor: An Explanation for Decreased Thyroid Function in Systemic Illness?
- 1 January 1991
- journal article
- research article
- Published by Mary Ann Liebert Inc in Thyroid®
- Vol. 1 (3) , 235-240
- https://doi.org/10.1089/thy.1991.1.235
Abstract
Thyroidal economy in systemic nonthyroidal illness (the sick euthyroid syndrome) is marked by reductions in both thyroid function and peripheral T4 to T3 conversion, presumed to reflect a homeostatic mechanism to conserve energy. TSH levels tend to be normal in these patients, and the mechanism underlying reduced thyroidal secretion is unknown. Since increased blood levels of tumor necrosis factor (TNF) are found in many of the conditions associated with the sick euthyroid syndrome, we hypothesized that TNF might affect the function of the thyroid gland. We, therefore, explored the effects of TNF on TSH stiumlation of the thyroid, employing a human thyrocyte cell culture model. Cells were incubated with various concentrations (0–1000 pg/mL) of recombinant human TNF-α and bTSH (1 mU/mL), with measurement of secreted thyroglobulin (Tg) and cyclic AMP (cAMP) as the end points of stimulation. TNF had no effect on either basal or TSH-stimulated cAMP generation, but significantly blunted TSH-stimulated Tg secretion. No loss of cell viability and growth was observed based on trypan blue exclusion and thymidine incorporation by cells. These studies demonstrated an inhibitory effect of TNF on human thyrocytes in concentrations comparable to blood levels seen in humans during systemic illness. We conclude that increases in serum TNF may be responsible for reduced thyroid function in patients with the sick euthyroid syndrome.Keywords
This publication has 17 references indexed in Scilit:
- Decreased Serum Triiodothyronine Is Associated with Increased Concentrations of Tumor Necrosis FactorJournal of Clinical Endocrinology & Metabolism, 1990
- Impairment of Hypothalamic-Pituitary-Thyroid Function in Rats Treated with Human Recombinant Tumor Necrosis Factor-α (Cachectin)*Endocrinology, 1989
- Effects of Tumor Necrosis Factor-α/Cachectin on Thyroid Hormone Metabolism in Mice*Endocrinology, 1988
- Tumor Necrosis Factor and Interleuktn-1 in the Serum of Children with Severe Infectious PurpuraNew England Journal of Medicine, 1988
- Cachectin (Tumor Necrosis Factor): A Macrophage Hormone Governing Cellular Metabolism and Inflammatory ResponseEndocrine Reviews, 1988
- Intrinsic abnormality of thyroid cells from a patient with a Brobdingnagian goiterJournal of Endocrinological Investigation, 1987
- ASSOCIATION BETWEEN TUMOUR NECROSIS FACTOR IN SERUM AND FATAL OUTCOME IN PATIENTS WITH MENINGOCOCCAL DISEASEThe Lancet, 1987
- RELATIONSHIP OF ALTERED THYROID HORMONE INDICES TO SURVIVAL IN NONTHYROIDAL ILLNESSESClinical Endocrinology, 1982
- Alterations in Thyroid Function in Patients with Systemic Illness: The “Euthyroid Sick Syndrome”*Endocrine Reviews, 1982
- Hypothyroxinemia in critically ill patients as a predictor of high mortalityJAMA, 1981